[Normovolemic hemodilution in the treatment of sudden deafness].
After the apparition of a sudden deafness, 45 patients (22 men and 23 women, with a mean age of 44 +/- 14.9 years) were treated with normovolaemic haemodilution performed with dextran 60. They were placed into 4 groups depending on their hearing loss: total loss: 10 cases; severe loss: 90 to 70 db. 13 cases; moderates loss: 65 to 40 db, 14 cases, slight loss: less than or equal to 35 db, 8 cases. The mean time between the onset of the hearing loss and treatment was 9.3 +/- 12.4 days. The initial mean haematocrit was 44.8 +/- 3.8% and mean haematocrit after haemodilution was 33.1 +/- 2.8%. For 51% of the patients, an almost total recovery was obtained. In 15.5% of cases, recovery was between 25 to 50% of the hearing loss, and in 33.3% of the patients recovery was negligible. We did not find any relationship between hearing recovery and initial haematocrit. The best results were obtained in the group of patients treated early. Hearing gain was significatively better if delay in starting treatment was less than 7 days. There was a relationship between the initial hearing loss and the final recuperation. These results suggested that haemodilution increased labyrinth microcirculation and oxygenation of the cochlear sensory cells, reversing the ischaemic insult to these cells.
D000328:Adult; D000368:Aged; D005260:Female; D034381:Hearing Loss / Q000097:blood / Q000628:therapy; D003639:Hearing Loss, Sudden / Q000097:blood / Q000628:therapy*; D006400:Hematocrit; D006438:Hemodilution / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged
Apport de l'hémodilution normovolémique au traitement des surdités brusques.